BIOS Fund II, LP, Director, 10% Owner at ACTUATE THERAPEUTICS, INC. (ACTU), bought 71,428 shares at $7.00 ($500K) on 2025-06-27, disclosed to the SEC on 2025-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| INAB | BUY | 2022-08-17 | $6.7M | — | Filing → |